Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

10.30
Delayed Data
As of 3:59pm ET
 +0.09 / +0.88%
Today’s Change
7.41
Today|||52-Week Range
23.11
-24.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.001.8M282.0K388.0K
 
 
 
 
Depreciation And Amortization587.2K666.6K1.2M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income-587.2K------
 
 
General Expenses9.3M15.7M48.2M66.5M
 
 
 
 
 
Research And Development7.0M11.0M33.6M51.3M
 
 
 
 
 
Total Operating Expenses9.9M16.4M49.4M68.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-14.6M-49.1M-68.4M
 
 
 
 
 
Extraordinary Charge0.00-67.6M0.000.00
 
 
Interest Expense On Debt50.7K1.8M12.0K1.8M
 
 
 
 
 
Other Expenses1.9M0.00-42.0K-10.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.0M-84.0M-48.5M-69.2M
 
 
 
 
 
Preferred Dividend-1.1M-1.4M0.000.00
 
 
 
Net Income-8.0M-84.0M-48.5M-69.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.0M2.5M26.3M27.0M
 
 
 
 
 
Shares To Calculate EPS Diluted27.0M2.5M26.3M27.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.09-$34.04-$1.84-$2.57
 
 
 
 
 
EPS Diluted-$3.09-$34.04-$1.84-$2.57